Picture BIO Deutschland EBDC 2016 Frankfurt 600x60px
Document › Details

Proteros Biostructures GmbH. (3/16/11). "Press Release: Proteros and CHDI Foundation, Inc. Establish Discovery Services Collaboration to Address Huntington’s Disease". Martinsried.

Organisations Organisation Proteros Biostructures GmbH
  Group Proteros (Group)
  Organisation 2 CHDI Foundation Inc.
Products Product structure-based drug design
  Product 2 drug discovery services
Persons Person D’Cruz, Cony (Proteros 201008– CBO + President Proteros US Inc before Evotec SVP North America)
  Person 2 Herrenknecht, Kurt (SciArcum 201110– before Proteros + Zukunftsfonds Heilbronn + PerkinElmer + Evotec + Eisai)

Proteros Biostructures GmbH (Proteros) announced today that it has entered into a service agreement with CHDI Foundation, Inc. (CHDI), under which Proteros will provide structure-based drug discovery services to CHDI. Proteros will apply its integrated discovery platform including proprietary X-ray crystallography tools to help CHDI in its mission to develop therapeutics that slow the progression of Huntington.s disease (HD).

Cony D.Cruz Chief Business Officer and President Proteros US, Inc. stated, “CHDI has been at the forefront of using a best-in-class network to assist in developing therapies for HD. We welcome the opportunity for Proteros to contribute to this effort.”

About Proteros:

Proteros is a privately held company that provides services and proprietary technologies to support integrated drug discovery. Proteros uses its technical expertise, industrial processes and unique technologies for crystallography, kinetic and thermodynamic profiling and fragment-based lead generation incorporating protein structure inspired compound and fragment libraries. The platform enables .knowledge driven lead engineering. to accelerate and improve protein structure analysis and structure-based drug discovery. Proteros complements its clients. internal capabilities with external expertise and access to flexible resources. Proteros currently provides services to more than 80 pharmaceutical and biotechnology clients in North America, Europe and Japan. Proteros US, Inc. is a wholly owned subsidiary of Proteros established to serve the growing customer base in North America.

About CHDI Foundation:

CHDI Foundation, Inc. is a privately-funded, not-for-profit, scientific organization exclusively dedicated to rapidly discovering and developing therapies that slow the progression of Huntington.s disease. As a collaborative enabler, CHDI seeks to bring the right partners together to identify and address critical scientific issues and move drug candidates to clinical evaluation as quickly as possible. CHDI scientists work closely with a network of more than 600 researchers in academic and industrial laboratories around the world in the pursuit of these novel therapies, providing project management to ensure that our common goals remain in focus. More information about CHDI can be found at


Proteros biostructures GmbH
Kurt Herrenknecht, Ph.D.
Am Klopferspitz 19
82152 Martinsried
Phone: +49 (0) 89 7007 61 0

CHDI Foundation, Inc.
Simon Noble, Ph.D.
Director, Scientific Communications
CHDI Management/CHDI Foundation
Phone: +1 212 660 8112

Record changed: 2016-03-19


Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Proteros (Group)

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2016 Frankfurt 120x240px Picture EBD Group BioPharm America 2016 BPA Boston September 120x80px Picture [LSE] – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px